Tumors of the small and large intestines - PowerPoint PPT Presentation

1 / 54
About This Presentation
Title:

Tumors of the small and large intestines

Description:

Title: Tumors of the small and large intestine Author: Dr.Maha Last modified by: Dr.Maha Created Date: 8/16/2006 12:00:00 AM Document presentation format – PowerPoint PPT presentation

Number of Views:584
Avg rating:3.0/5.0
Slides: 55
Provided by: Dr1261
Category:

less

Transcript and Presenter's Notes

Title: Tumors of the small and large intestines


1
Tumors of the small and large intestines
  • Non-neoplastic polyps
  • Neoplastic ( epithelial) polyps
  • Mesenchymal lesions
  • Lymphoma

2
Tumors of the small and large intestine
  • Epithelial tumors are a major cause of morbidity
    and mortality worldwide
  • The colorectal cancer is the GIT segment most
    commonly affected by tumors
  • It is the host to more primary tumors than any
    other tumor of the body.
  • Colonic carcinoma is second to bronchogenic
    carcinoma as a cause of death in USA.
  • Adenocarcinoma in colorectum represent 70 of all
    malignancy of GIT
  • Benign tumors, primarily epithelial, are present
    in 25 to 50 of older adults.

3
Terminology of Intestinal Tumors
  • Polyps and Polyposis Syndromes
  • Polyp is a mucosal growth that protrude into the
    lumen of gut. It could be sessile or pedunculated
  • Polyps may be formed as the result of abnormal
    mucosal maturation, inflammation, or as
    epithelial proliferation with dysplasia

4
Terminology of Intestinal Tumors
  • Polypoid lesions is the inflammatory masses,
    hamartomas and tumors arising from the submucosa
    or muscle coat, but also protruding into the
    lumen.
  • Polyposis is multiple polyps.
  • Polyposis syndrome is hereditary, characterized
    by the presence of multiple pedunculated or
    sessile tumors of the mucosa

5
Tumors of the small and large intestineClassifica
tion
  • Non-neoplastic polyps
  • Hyperplastic polyps
  • Hamartomatous polyps (Juvenile Peutz-Jeghers
    polyps)
  • Inflammatory polyps
  • Lymphoid polyps
  • Neoplastic ( epithelial) polyps
  • Benign polyps (adenoma)
  • Malignant lesions
  • Adenocarcinoma
  • Carcinoid
  • Anal zone carcinoma
  • Mesenchymal lesions
  • GIT stromal tumors (benign malignant)
  • Others ( lipoma, neuroma, angioma, Kaposi
    sarcoma)
  • Lymphoma

6
Intestinal Polyps
  • Non-Neoplastic Polyps
  • Represent 90 of all epithelial polypi found in
    large intestine.
  • Found in more than half of all persons age 60
    years or older.
  • Types 1. Hyperplastic polyp.
  • 2. Hamartomatous polyp
    (Juvenile Peutz- Jeghers)
  • 3. Inflammatory polyp
  • 4. Lymphoid polyp

7
Intestinal Polyps
  • 1 Hyperplastic Polyp
  • Asymtomatic
  • gt 50 are located in the rectosigmoid, 20 in
    the ascending colon.
  • Smooth, moist, round, small (0.5cm) sessile
    lesions.
  • Multiple polyps are frequent.
  • Composed of well-formed glands and crypts lined
    by differentiated goblet or absorptive cells.
  • Pure hyperplastic polyps have no malignant
    potential.
  • Larger hyperplastic polyps foci of adenomatous
    change.

8
Non-Neoplastic Polyp
  • 2 Hamartomatous polyp
  • Juvenile Polyps (retention polyp)
  • Developmental malformations affecting the glands
    and lamina propria, having no malignant
    potential.
  • commonly occur in children under 5 years old in
    the rectum. In adult called retention polyp.
  • Painless rectal bleeding after defecation.
  • Large, rounded, smooth lesions with a stalk
  • Histology mucus-filled, cystically dilated
    tubules lined by normal or inflamed mucosa.
  • Juvenile polyposis syndrome. Occurrence of
    multiple hamartomatous polyps throughout the GI
    tract.

9
Non-Neoplatic Polyps
  • 2 Hamartomatous Polyps
  • Peutz-Jehgers polyps
  • Uncommon hamartomatous polyps accompanied by
    mucosal and cutaneous pigmentation around the
    lips, oral mucosa, face and genitalia.
  • Rare, autosomal dominant.
  • Caused by germ-line mutation in the LKB1 gene,
    which encodes a serine threonine kinase.
  • Polyps tend to be large and pedunculated.
  • May occur anywhere in the GI tract.
  • Have an increased risk of developing carcinoma of
    the pancreas, breast, lung, ovary and uterus.

10
hamartomatous polyp
11
Non-Neoplastic Polyps
  • 3 Inflammatory Polyps
  • Occur in patients with longstanding IBD,
    especially in chronic ulcerative colitis.
  • Usually multiple.
  • Represent an exuberant reparative response to
    longstanding mucosal injury called pseudopolyps

12
4 Lymphoid polyps
13
Neoplastic Polyps (Adenomas)
  • Adenomatous Polyp
  • Occur mainly in large bowel.
  • Prevalence 20 to 30 before age 40, 50 after
    age 60.
  • Males and females are equally affected
  • Spordic and familial
  • Vary from small pedunculated to large sessile
  • Epithelium proliferation and dysplastia with
    loss of basal orientation of nuclei
    (pseudostratified).
  • Divided into
  • Tubular adenoma has less than 25 villous
    architecture
  • Villous adenoma villous architecture over 50
  • Tubulovillous adenoma villous architecture
    between 25 and 50.

14
  • All adenomatous lesions arise as the result of
    epithelial proliferation and dysplasia, which may
    range from mild to so severe as to represent
    transformation to carcinoma.

15
Neoplastic Polyps
  • 1 Tubular adenoma
  • Represents 75 of all neoplastic polyps.
  • Occurs sporadicaly and in well defined hereditary
    syndromes.
  • Average age is 60 years
  • 75 occur in the distal colon and rectum.
  • More than 50 occur singly.
  • Size few millimeters (sessile) to many
    centimeters (have stalk).
  • Stalk has a central core of fibrovascular tissue,
    covered with dysplastic colonic mucosa.
  • Severe dysplasia and invasive carcinoma may
    supervene.

16
Tubular adenoma
17
Neoplastic Polyps
  • 2 Villous Adenoma
  • The least common, largest and most ominous of
    epithelial polyps.
  • Age 60 to 65 years, MF ratio roughly equal.
  • Present with rectal bleeding or anemia, large
    ones may secrete copious amounts of mucoid
    material rich in protein.
  • 75 located in rectosigmoid area.

18
Neoplastic Polyps
  • 2 Villous Adenoma
  • Morphology
  • Size 1 to 10 cm in diameter.
  • Most are broad, sessile, velvety lesions
    projecting 1 to 3 cm.
  • Frondlike papillary projections of adenomatous
    epithelium with a delicate fibrovascular core.
  • All degree of dysplasia with frank invasive
    carcinoma in up to 40.

19
Neoplastic Polyps
  • 3 Tubulovillous adenoma
  • Intermmediate in size, frequency of having a
    stalk, degree of dysplasia and malignant
    potential between tubular and villous adenomas.

20
Neoplastic Polyps
  • Clinical features
  • The smaller adenomas are usually asymptomatic,
    occult bleeding.
  • Villous adenomas are much more frequently
    symptomatic because of overt or occult rectal
    bleeding or mucoid material rich in protein and
    potassium to produce hypoproteinemia or
    hypokalemia.
  • Adenomas in the immediate vicinity of the ampulla
    of Vater may produce biliary obstruction.

21
Relationship of Neoplastic Polyps to Carcinoma
  • Adenoma to carcinoma sequence is documented by
    several observations and genetic alterations.
  • The probability of carcinoma occuring in a
    neoplastic polyp is related to
  • 1. The size of the polyp.
  • 2. The relative proportion of its villous
    features.
  • 3. The presence of significant cytologic atypia
  • (dysplasia) in the neoplastic cells.

22
Familial Polyposis Syndrome
  • Patients have genetic tendencies to develop
    neoplastic polyps, most often autosomal dominant.
  • Familial polyposis coli (FPC)
  • Genetic defect ch5 q21.
  • Innumerable neoplastic polyps in the colon (500
    to 2500)
  • Polyps are also found elsewhere in alimentary
    tract
  • Most polyps are tubular adenomas
  • The risk of colorectal cancer is 100 by midlife.
  • Gardeners syndrome
  • Polyposis coli, multiple osteomas, epidermal
    cysts, and fibromatosis.
  • Turcot syndrome
  • Polyposis coli, glioma and fibromatosis

23
(No Transcript)
24
Malignant Tumors of Large IntestineAdenocarcinoma
  • Constitutes 98 of all cancers in the large
    intestine.
  • Worldwide distribution, highest incidence in
    west.
  • Causes 15 of all cancer-related death in the
    USA.
  • The mortality rate and incidence is higher in
    blacks.
  • Peak incidence in the sixth to seventh decade.

25
Malignant Tumors of Large IntestineAdenocarcinoma
  • Predisposing factors IBD, polyposis syndrome.
  • Malefemale ratio is 21 in rectal cancer,
    roughly equal in colon cancer, generally males
    are affected about 20 more than females.
  • Diet appears to play an important role in the
    risk for colon cancer
  • - Low content of unabsorpable vegetable fibre.
  • - High content of refined carbohydrates.
  • - High fat content.
  • - ? Increased intake of nitrites, nitrates
    (nitrosamines).
  • - Reduced intake of vit A, C E.
  • The use of aspirin and NSAID (cyclooxygenase-2
    inhibitors) exerts a protective effect against
    colon cancer

26
  • When colorectal cancer is found in a young
    person, preexisting ulcerative colitis or one of
    the polyposis syndromes must be suspected.
  • Individuals with hereditary nonpolyposis
    colorectal cancer syndrome (HNPCC, also known as
    Lynch syndrome), caused by germ-line mutations of
    DNA mismatch repair genes, are at a high risk of
    developing colorectal cancers.
  • (HNPCC patients are also at risk of developing
    other tumors, such as cholangiocarcinomas.)

27
Malignant Tumors of Large IntestineAdenocarcinoma
  • Colorectal carcinogenesis
  • Two pathogenetically distinct pathways for the
    development of colon cancer, both seem to result
    from accumulation of multiple mutations
  • The APC/B-catenin pathway
  • chromosomal instability that results in stepwise
    accumulation of mutations in a series of
    oncogenes and tumor suppressor genes.
  • Localized colon epithelial proliferation followed
    by the formation of small adenomas, become more
    dysplastic, and ultimately develop into invasive
    cancers.

28
Malignant Tumors of Large IntestineAdenocarcinoma
Colorectal carcinogenesis
This adenoma-carcinoma sequence accounts for
aboout 80 of sporadic colorectal cancers.
29
Malignant Tumors of Large IntestineAdenocarcinoma
  • The DNA mismatch repair genes pathway
  • 10 to 15 of sporadic cases.
  • There is accumulation of mutations (as in the
    APC/B-catenin schema) but the involved genes
    are different.
  • Unlike in the adenoma-carcinoma sequence, there
    are no clearly identifiable morphologic
    correlates

30
Malignant Tumors of Large IntestineAdenocarcinoma
  • In DNA mismatch repair genes pathway defective
    DNA repair caused by inactivation of DNA mismatch
    repair genes is the fundamental and the most
    likely initiating event in colorectal cancers
  • Inherited mutations in one of five DNA mismatch
    repair genes (MSH2, MSH6, MLH1, PMS1, AND PMS2)
    give rise to the hereditary non polyposis colon
    carcinoma (HNPCC)
  • MLH1 gene is the one most commonly involved in
    sporadic colon carcinomas

31
Malignant Tumors of Large IntestineAdenocarcinoma
  • Microsatellite instability (MSI) is the molecular
    signature of defective DNA mismatch repair
  • Most microsatellite sequences are in noncoding
    regions of the genes so mutations in these genes
    are probably harmless.
  • However, some micorsatellite sequences are
    located in the coding or promoter region of genes
    involved in regulation of cell growth.

32
HNPCC
33
Colorectal Carcinoma
  • Morphology
  • Sixty to 70 of colorectal carcinomas are in the
    rectum, rectosigmoid and sigmoid colon.
  • Left-sided carcinomas tend to be annular,
    encircling lesions with early symptoms of
    obstruction.
  • Neoplasms start superficially, slowly invading
    the deeper layers with ulceration and eventually
    metastasis.

34
(No Transcript)
35
Colorectal Carcinoma
  • Morphology
  • Right-sided carcinomas tend to grow as polypoid,
    fungating masses, obstruction is uncommon.
  • Invasion of the wall and extend to the mesentery,
    regional lymph nodes and more distal sites.
  • Mucinous adenocarcinoma secret abundant mucin
    that may dissect through cleavage planes in the
    wall.
  • Small cell undifferentiated carcinomas are rare
    (arising from neuroendocrine cells)
  • In UC, poorly differentiated infiltrative
    adenocarcinoma without an exophytic growth.

36
(No Transcript)
37
(No Transcript)
38
Colorectal Carcinoma
  • Clinical features
  • The condition tends to be present for a
    considerable time before producing symptoms.
  • Left-sided lesions tend to present earlier but
  • also have a more infiltrative growth pattern
    and a poorer prognosis.
  • Right-sided lesions tend to present with
    weakness, malaise, weight loss, unexplained
    anemia (secondary to early bleeding).

39
Colorectal Carcinoma
  • Spread - direct extension.
  • - metastasis through
  • - lymphatic
  • - blood vessels
  • - favored sites are regional lymph node,
    liver, lungs, bones.
  • Serum levels of carcinoembryonic antigen (CEA)
    are related to tumor size and extent of spread.
    They are helpful in monitoring for recurrence of
    tumor after resection.
  • Overall 5-year survival is 35 to 49 in the
    United States.

40
(No Transcript)
41
(No Transcript)
42
(No Transcript)
43
Colorectal Neoplasm
  • Other Tumors
  • Malignant spindle cell (mesenchymal) tumors and
    lymphomas.
  • Grossly and microscopically resemble those
    arising elsewhere in the GI tract.
  • Carcinoid tumors may arise anywhere in the colon,
    especially the rectum.
  • Squamous cell carcinomas are largely limited to
    the rectal canal. Initially present as
    plaque-like lesions, later becoming ulcerated or
    fungating.
  • Malignant melanoma at the anal verge.

44
Small Intestinal Neoplasms
  • 3-6 of GIT neoplasm, slight preponderance to
    benign tumors.
  • BENIGN
  • Discovered incidentally, leiomyoma, adenoma and
    lipoma
  • Large lesions may cause obstruction, bleeding,
    intussusception, volvulus.
  • ADENOMAS
  • Single or multiple polyps, most often in the
    duodenum and ileum.
  • There is a risk of malignancy with larger
    adenomatous polyps.
  • MALIGNANT
  • In descending order of frequency carcinoid,
    adenocarcinomas, lymphomas and leiomyosarcomas.
  • Leiomyosarcomas have tyrosine kinase receptors,
    can be treated by STI-571

45
Small Intestinal Neoplasms
  • Adenocarcinoma of small intestine
  • Tumors grow as polypoid fungating ulcerating mass
    or encircling pattern
  • Site duodenum ( ampulla of Vater)
  • Presentation abdominal cramping pain, vomiting
    and weight loss
  • Patients present late
  • 5 years survival is 70 after en bloc resection

46
Small Intestinal Neoplasms
  • Carcinoid Tumors
  • Neoplasms arising from endocrine cells Kulchitsky
    or enterochromaffin cells found along the length
    of GIT mucosa. Cells have an affinity for silver
    salts.
  • 60 to 80 appendix and terminal ileum 10 to 20
    rectum, the remainder in the stomach, duodenum or
    esophagus.
  • Other Location Lungs, pancreas, biliary tract,
    ovaries and liver.
  • Peak age 6th decade, comprise 2 of colorectal
    carcinoma and 50 of small intestinal carcinoma.
  • Tumors in the appendix and rectum, although
    spreading locally, seldom metastasize.
  • Ileal, gastric, and colonic carcinoids are
    frequently malignant.

47
Carcinoid Tumors
  • Morphology
  • Round submucosal elevations that are bright
    yellow or yellow-gray, may be deeply
    infiltrative and penetrate muscle to the serosa.
  • Gastric and ileal carcinoids are frequently
    multiple.
  • Tumor cells arranged in trabecular, insular,
    glandular or undifferentiated patterns are
    monotonously similar to each other with regular
    round nuclei
  • Ultrastructral features neurosecretory
    electron dense bodies in the cytoplasm

48
Small Intestinal Neoplasms
  • Carcinoid Tumor
  • Clinical features
  • Asymptomatic
  • May cause obstruction, intussusception or
    bleeding.
  • May elaborate hormones Zollinger-Ellison,
    Cushings carcinoid or other syndromes.
  • 5 years survival rate is 90, small bowel
    Carcinoid with liver metastasis the 5 years
    survival rate is better than 50

49
Small Intestinal Neoplasms
  • Carcinoid tumor
  • Carcinoid syndrome
  • Syndrome occur in 1 of all pt. with carcinoid
    in 20 of those of widespread metastasis
  • Paroxymal flushing, episodes of asthma-like
    wheezing, right-sided heart failure, attacks of
    watery diarrhea, abdominal pain, edema and
    pellagra-like lesions of the skin and oral
    mucosa.
  • The principal chemical mediator is serotonin
    (5-hydroxy-tryptamine-5HT).
  • 5-HT is decarboxylated in the liver and lungs to
  • 5-hydroxy-indoleacetic acid (5HIAA)
  • The syndrome is classically associated with ileal
    carcinoids with hepatic metastases.

50
Small Intestinal Neoplasms
  • Lymphoma
  • Up to 40 of lymphomas arise in sites other than
    lymph nodes, gut is the most.
  • 1 to 4 of all gastrointestinal malignancies are
    lymphomas.
  • Primary GIT lymphomas exhibit no evidence of
    liver, spleen, or bone marrow involvement at the
    time of diagnosis.

51
Small Intestinal Neoplasms
  • Lymphoma
  • Sporadic lymphoma arise from the B cells of
    mucosa-associated lymphoid tissue (MALT).
  • This usually affects adults, lacks a sex
    predilection, and may arise anywhere in the gut
    stomach - 55 to 60 -
  • small intestine - 25 to 30 -
  • proximal colon - 10 to 15 -
  • distal colon - up to 10 -

52
Small Intestinal Neoplasms
  • Lymphoma
  • Gastric MALT lymphomas arise in the setting of
    mucosal lymphoid activation, as a result of
    Helicobacter associated chronic gastritis.
  • Celiac disease is associated with a higher than
    normal risk of T-cell lymphomas.

53
Small Intestinal Neoplasms
  • Lymphoma
  • Primary GIT lymphomas have a better prognosis
    than do those arising in other sites.
  • Treatment combined surgery, chemotherapy, and
    radiation therapy.

54
Thank you
Write a Comment
User Comments (0)
About PowerShow.com